Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 709 (USA) (Dr. Novak)
· consented 2013-08-02
Adverse events
6
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
moderate
assessed
2026-08-18
Moderate PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-06 (study day 36.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate PRURITUS — outcome: RECOVERED/RESOLVED; onset 2013-09-06 (study day 36.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-06 (study day 36.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate RASH — outcome: RECOVERED/RESOLVED; onset 2013-09-06 (study day 36.0); relationship: PROBABLE
mild
assessed
2026-08-18
Mild SKIN IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-08-17 (study day 16.0); relationship: PROBABLE
mild
assessed
2026-08-18
Mild SKIN IRRITATION — outcome: RECOVERED/RESOLVED; onset 2013-08-17 (study day 16.0); relationship: PROBABLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.